Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aaron I. Davis currently holds 65,000 shares of iTeos Therapeutics, Inc. (ITOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron I. Davis has been a net buyer of ITOS stock. They have purchased $110.4M and sold $38.3M worth of shares.
Aaron I. Davis's most recent insider trade was on Sep 3, 2024, when they sold 65,000 shares at $0.00 per share.
Aaron I. Davis serves as Executive at iTeos Therapeutics, Inc. (ITOS). They have executed 76 insider transactions totaling $148.7M over their tenure at the company.
Aaron I. Davis holds the position of Executive at iTeos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Aaron I. Davis has shown a buying trading pattern, with $110.4M in total purchases and $38.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Aaron I. Davis was on May 10, 2024, when they purchased $20.0M worth of ITOS shares. This transaction involved 1,142,857 shares at $17.50 per share.
Aaron I. Davis currently owns 65,000 shares of iTeos Therapeutics, Inc. (ITOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aaron I. Davis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aaron I. Davis has 76 Form 4 filings on record as an insider at iTeos Therapeutics, Inc..
Set alerts for Aaron I. Davis and 40,000+ other insiders.